BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma
April 20, 2026
April 20, 2026
PHILADELPHIA, Pennsylvania, April 20 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma
*
All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of follow-up
SAN DIEGO - A single in . . .
* * *
BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma
*
All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of follow-up
SAN DIEGO - A single in . . .